Select Publications

Journal articles

Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV, 2019, 'Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients', Clinical Neurophysiology, 130, pp. 2088 - 2095, http://dx.doi.org/10.1016/j.clinph.2019.08.005

Ahmed R; Devenney E; Hodges J; Piguet O; Kiernan M, 2019, 'Effect of phenotypic presentation on survival in ALS-FTD', JOURNAL OF THE NEUROLOGICAL SCIENCES, 405, http://dx.doi.org/10.1016/j.jns.2019.10.323

Ahmed R; Landin-Romero R; Liang C; Keogh J; Henning E; Emma D; Hodges J; Kiernan M; Sadaf F; Piguet O, 2019, 'Neural correlates of body composition in frontotemporal dementia', JOURNAL OF THE NEUROLOGICAL SCIENCES, 405, http://dx.doi.org/10.1016/j.jns.2019.10.840

Vucic S; Westeneng HJ; Al-Chalabi A; Van Den Berg LH; Talman P; Kiernan MC, 2019, 'Amyotrophic lateral sclerosis as a multi-step process: an Australia population study', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 532 - 537, http://dx.doi.org/10.1080/21678421.2018.1556697

Gold J; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RPA; Nath A; Garcia Montojo M; Norato G; Santamaria UA; Rogers ML; Malaspina A; Lombardi V; Mehta PR; Westeneng HJ; van den Berg LH; Al-Chalabi A, 2019, 'Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 595 - 604, http://dx.doi.org/10.1080/21678421.2019.1632899

Li T; Timmins H; King T; Kiernan M; Goldstein D; Park S, 2019, 'Bortezomib Induced Peripheral Neuropathy: A Systematic Review of Phase III Trials', CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, pp. E346 - E346, http://dx.doi.org/10.1016/j.clml.2019.09.571

Besomi M; Hodges PW; Van Dieën J; Carson RG; Clancy EA; Disselhorst-Klug C; Holobar A; Hug F; Kiernan MC; Lowery M; McGill K; Merletti R; Perreault E; Søgaard K; Tucker K; Besier T; Enoka R; Falla D; Farina D; Gandevia S; Rothwell JC; Vicenzino B; Wrigley T, 2019, 'Consensus for experimental design in electromyography (CEDE) project: Electrode selection matrix', Journal of Electromyography and Kinesiology, 48, pp. 128 - 144, http://dx.doi.org/10.1016/j.jelekin.2019.07.008

Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM, 2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263

Kiernan MC; Ziemann U; Eisen A, 2019, 'Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period', Muscle and Nerve, 60, pp. 232 - 235, http://dx.doi.org/10.1002/mus.26617

McMackin R; Muthuraman M; Groppa S; Babiloni C; Taylor JP; Kiernan MC; Nasseroleslami B; Hardiman O, 2019, 'Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 1011 - 1020, http://dx.doi.org/10.1136/jnnp-2018-319581

Higashihara M; Menon P; Geevasinga N; Van den Bos MAJ; Kiernan MC; Vucic S, 2019, 'Motor neuron disease with malignancy: Clinical and pathophysiological insights', Clinical Neurophysiology, 130, pp. 1557 - 1561, http://dx.doi.org/10.1016/j.clinph.2019.05.026

Ahmed RM; Landin-Romero R; Liang CT; Keogh JM; Henning E; Strikwerda-Brown C; Devenney EM; Hodges JR; Kiernan MC; Farooqi IS; Piguet O, 2019, 'Neural networks associated with body composition in frontotemporal dementia', Annals of Clinical and Translational Neurology, 6, pp. 1707 - 1717, http://dx.doi.org/10.1002/acn3.50869

Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ, 2019, 'Neuroinflammation in frontotemporal dementia', Nature Reviews Neurology, 15, pp. 540 - 555, http://dx.doi.org/10.1038/s41582-019-0231-z

Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC, 2019, 'Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy', European Journal of Neurology, 26, pp. 1121 - 1129, http://dx.doi.org/10.1111/ene.13953

Menon P; Yiannikas C; Kiernan MC; Vucic S, 2019, 'Regional motor cortex dysfunction in amyotrophic lateral sclerosis', Annals of Clinical and Translational Neurology, 6, pp. 1373 - 1382, http://dx.doi.org/10.1002/acn3.50819

Edwards LS; Halmagyi GM; Barnett MH; Blair CA; Kiernan MC, 2019, 'Cerebellar oedema in fulminant adult leigh syndrome', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.79

Higashihara M; Menon P; Geevasinga N; Van den Bos MAJ; Kiernan MC; Vucic S, 2019, 'MOTOR NEURON DISEASE WITH MALIGNANCY: CLINICAL AND PATHOPHYSIOLOGICAL INSIGHTS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.80

Arnold R; Pianta TJ; Pussell BA; Endre Z; Kiernan MC; Krishnan AV, 2019, 'Potassium control in chronic kidney disease: implications for neuromuscular function', Internal Medicine Journal, 49, pp. 817 - 825, http://dx.doi.org/10.1111/imj.14114

Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M, 2019, 'Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders', International Journal of Molecular Sciences, 20, http://dx.doi.org/10.3390/ijms20133161

Huynh W; Sharplin LE; Caga J; Highton-Williamson E; Kiernan MC, 2019, 'RESPIRATORY FUNCTION AND COGNITIVE PROFILE IN MOTOR NEURON DISEASE', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.38

Van den Bos M; Howells J; Higashihara M; Geevasinga N; Kiernan M; Vucic S, 2019, 'ROLE OF TRANSCALLOSAL INHIBITION IN DISEASE SPREAD IN ALS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.18

Borire A; Issar T; Kwai N; Visser L; Poynten A; Simon N; Kiernan M; Krishnan A, 2019, 'THE UTILITY OF NERVE BLOOD FLOW IN THE ASSESSMENT OF PERIPHERAL NEUROPATHY', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.24

Devenney EM; Ahmed RM; Caga J; Highton-Williamson E; Ramsey E; Zoing M; Hodges J; Kiernan M, 2019, 'Unravelling psychosis in motor neurone disease - a study of clinical features, cognition, and survival', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.15

Tu S; Turner MR; Kiernan MC, 2019, 'WIDESPREAD EXTRA-MOTOR ABNORMALITY IS A PROMINENT MRI SIGNATURE OF ALS: A CROSS-COHORT STUDY', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, http://dx.doi.org/10.1136/jnnp-2019-anzan.17

Kiernan MC; Goadsby PJ; Burke D, 2019, 'Marco polo of australian neurology', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 627 - 628, http://dx.doi.org/10.1136/jnnp-2019-320989

Nathani D; Barnett MH; Spies J; Pollard J; Wang MX; Kiernan MC, 2019, 'Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome', Muscle and Nerve, 59, pp. 643 - 649, http://dx.doi.org/10.1002/mus.26431

Henderson RD; Garton FC; Kiernan MC; Turner MR; Eisen A, 2019, 'Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 570 - 575, http://dx.doi.org/10.1136/jnnp-2017-317245

Agarwal S; Ahmed RM; D'Mello M; Foxe D; Kaizik C; Kiernan MC; Halliday GM; Piguet O; Hodges JR, 2019, 'Predictors of survival and progression in behavioural variant frontotemporal dementia', European Journal of Neurology, 26, pp. 774 - 779, http://dx.doi.org/10.1111/ene.13887

Dharmadasa T; Matamala JM; Howells J; Simon NG; Vucic S; Kiernan MC, 2019, 'The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS', Neuroscience Letters, 699, pp. 84 - 90, http://dx.doi.org/10.1016/j.neulet.2019.01.050

Long Z; Irish M; Piguet O; Kiernan MC; Hodges JR; Burrell JR, 2019, 'Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia–motor neuron disease patients', Journal of Neurology, 266, pp. 921 - 933, http://dx.doi.org/10.1007/s00415-019-09216-0

Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR, 2019, 'Cerebellar tract alterations in PLS and ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 281 - 284, http://dx.doi.org/10.1080/21678421.2018.1562554

Anderson S; Kiernan M; Ho PJ, 2019, 'Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma', Clinical Lymphoma, Myeloma and Leukemia, 19, pp. e169 - e171, http://dx.doi.org/10.1016/j.clml.2018.12.021

Riggare S; Thurbon R; Roman S; Richards T; Kiernan MC, 2019, 'Patient Editorial Board for JNNP', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 369 - 370, http://dx.doi.org/10.1136/jnnp-2019-320453

Tan RH; Guennewig B; Dobson-Stone C; Kwok JBJ; Kril JJ; Kiernan MC; Hodges JR; Piguet O; Halliday GM, 2019, 'The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability', Neurology, 92, pp. E1354 - E1366, http://dx.doi.org/10.1212/WNL.0000000000007146

Ahmed RM; Phan K; Highton-Williamson E; Strikwerda-Brown C; Caga J; Ramsey E; Zoing M; Devenney E; Kim WS; Hodges JR; Piguet O; Halliday GM; Kiernan MC, 2019, 'Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia', Annals of Clinical and Translational Neurology, 6, pp. 486 - 495, http://dx.doi.org/10.1002/acn3.721

Kennett J; Carter A; Bourne JA; Hall W; Levy N; Mattingley JB; Lawrence AJ; Forlini C; Malcolm L; Vincent N; Richards LJ; Egan GF; Breakspear M; Cornish K; Halliday G; Poole-Warren L; Sriram S; Soulis T; Fitzgibbon B; Kiral-Kornek I; Badcock DR; Balleine B; Bekkers JM; Berk M; Bradley A; Brichta A; Carter O; Castles A; Clements J; Cornish J; de Zubicaray G; Enticott PG; Fornito A; Griffiths L; Gullifer J; Hannan AJ; Harrer S; Harvey A; Hickie IB; Jazwinska L; Kiernan M; Kilpatrick T; Leventer R; Licinio J; Lovell N; Mackellar G; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Rossell S; Sah P; Sarnyai Z; Schofield PR; Shum DHK; Silk T; Slee M; Stuart GJ; Tapson J; van Schaik A; Vissel B; Waters A; Apthorp D; Cohen-Woods S; Conn SJ; Korgaonkar M; Mason A; Azghadi MR; Shimoni O; Smith A; Thompson MB, 2019, 'A Neuroethics Framework for the Australian Brain Initiative', Neuron, 101, pp. 365 - 369, http://dx.doi.org/10.1016/j.neuron.2019.01.004

Geevasinga N; Howells J; Menon P; Van Den Bos M; Shibuya K; Matamala JM; Park SB; Byth K; Kiernan MC; Vucic S, 2019, 'Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS', Neurology, 92, pp. e536 - e547, http://dx.doi.org/10.1212/WNL.0000000000006876

Gu Y; Dennis SM; Kiernan MC; Harmer AR, 2019, 'Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: A systematic review', Diabetes/Metabolism Research and Reviews, 35, http://dx.doi.org/10.1002/dmrr.3099

Tazelaar GSHP; Dekker AM; van Vugt JJFA; van der Spek RA; Westeneng H-J; Kool LJBG; Kenna KP; van Rheenen W; Pulit SL; McLaughlin RL; Sproviero W; Iacoangeli A; Huebers A; Brenner D; Morrison KE; Shaw PJ; Shaw CE; Povedano Panades M; Mora Pardina JS; Glass JD; Hardiman O; Al-Chalabi A; van Damme P; Robberecht W; Landers JE; Ludolph AC; Weishaupt JH; van den Berg LH; Veldink JH; van Es MA; Akcimen F; Al Khleifat A; Andersen P; Basak AN; Bauer DC; Blair I; Brands WJ; Byrne RP; Calvo A; Gonzalez YC; Chio A; Cooper-Knock J; Corcia P; Couratier P; de Carvalho M; Drory VE; Eitan C; Garcia Redondo A; Gellera C; Gotkine M; Hornstein E; Kenna B; Kiernan MC; Kocoglu C; Kooyman M; Lopez Alonso V; Middelkoop B; Mill J; Mitne-Neto M; Moisse M; Pinto SC; Ratti A; Schellevis RD; Shatunov A; Silani V; Staiger C; Tazelaar GHP; Ticozzi N; Tunca C; Twine NA; van Doormaal PTC; van Eijk KR; Visscher PM; Vourch P; Weber M; Williams KL; Wray N; Yang J; Zatz M; Zhang K, 2019, 'Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort', NEUROBIOLOGY OF AGING, 74, http://dx.doi.org/10.1016/j.neurobiolaging.2018.09.012

Huynh W; Dharmadasa T; Vucic S; Kiernan MC, 2019, 'Functional biomarkers for amyotrophic lateral sclerosis', Frontiers in Neurology, 10, http://dx.doi.org/10.3389/fneur.2018.01141

Carroll AS; Burns J; Nicholson G; Kiernan MC; Vucic S, 2019, 'Inherited Neuropathies', Seminars in Neurology, 39, pp. 620 - 639, http://dx.doi.org/10.1055/s-0039-1693006

Agarwal S; Koch G; Hillis AE; Huynh W; Ward NS; Vucic S; Kiernan MC, 2019, 'Interrogating cortical function with transcranial magnetic stimulation: Insights from neurodegenerative disease and stroke', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 47 - 57, http://dx.doi.org/10.1136/jnnp-2017-317371

Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ, 2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, 9, pp. bmjopen-2018-023736, http://dx.doi.org/10.1136/bmjopen-2018-023736

Dharmadasa T; Kiernan MC, 2019, 'Sound of the crowd: Wisdom of neurologists revisited', Practical Neurology, 19, pp. 552, http://dx.doi.org/10.1136/practneurol-2019-002384

Ashworth A; Cutler C; Farnham G; Liddle L; Burleigh M; Rodiles A; Sillitti C; Kiernan M; Moore M; Hickson M; Easton C; Bescos R, 2019, 'Dietary intake of inorganic nitrate in vegetarians and omnivores and its impact on blood pressure, resting metabolic rate and the oral microbiome.', Free Radic Biol Med, 138, pp. 63 - 72, http://dx.doi.org/10.1016/j.freeradbiomed.2019.05.010

Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC, 2018, 'Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies with Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia', JAMA Neurology, 75, pp. 1519 - 1527, http://dx.doi.org/10.1001/jamaneurol.2018.2681

Noto YI; Garg N; Li T; Timmins HC; Park SB; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Yiannikas C; Vucic S; Kiernan MC, 2018, 'Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis', Muscle and Nerve, 58, pp. 777 - 783, http://dx.doi.org/10.1002/mus.26301

Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR, 2018, 'Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 89, pp. 1250 - 1258, http://dx.doi.org/10.1136/jnnp-2018-318625

Bueno APA; Pinaya WHL; Moura LM; Bertoux M; Radakovic R; Kiernan MC; Teixeira AL; de Souza LC; Hornberger M; Sato JR, 2018, 'Structural and functional papez circuit integrity in amyotrophic lateral sclerosis', Brain Imaging and Behavior, 12, pp. 1622 - 1630, http://dx.doi.org/10.1007/s11682-018-9825-0

Howells J; Matamala JM; Park SB; Garg N; Vucic S; Bostock H; Burke D; Kiernan MC, 2018, 'In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis', Journal of Physiology, 596, pp. 5379 - 5396, http://dx.doi.org/10.1113/JP276624


Back to profile page